Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan ter Meulen

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Journal of Infectious Diseases|October 12, 2011
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, GermanyStephan Günther, Heinz Feldmann, Thomas W Geisbert, et al.
Communications Biology|January 9, 2025
Carbonic anhydrase 2-derived drug-responsive domain regulates membrane-bound cytokine expression and function in engineered T cellsMara C Inniss, Sean G Smith, Dan Jun Li, et al.
Journal of Virology|July 1, 2006
Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile VirusMark Throsby, Cecile Geuijen, Jaap Goudsmit, et al.
Plos Medicine|June 27, 2006
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutantsJan ter Meulen, Edward N van den Brink, Leo L M Poon, et al.
Journal of Virology|January 15, 2005
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirusEdward N van den Brink, Jan Ter Meulen, Freek Cox, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2025
IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15Rachel A Burga, Bulent Arman Aksoy, Zheng Ao, et al.
Cancer Immunology Research|February 20, 2026
Potent cytotoxic tumor-infiltrating lymphocytes can be generated from immune-excluded chondrosarcomas using regulatable membrane-bound IL15Zheng Ao, Rusul Al-Marayaty, Bülent Arman Aksoy, et al.
Oncoimmunology|December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Frontiers in Oncology|June 5, 2026
Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case seriesJessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, et al.
JAMA Oncology|October 12, 2023
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled TrialYongwoo David Seo, Hailing Lu, Graeme Black, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Infectious Diseases|October 12, 2011
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, GermanyStephan Günther, Heinz Feldmann, Thomas W Geisbert, et al.
Communications Biology|January 9, 2025
Carbonic anhydrase 2-derived drug-responsive domain regulates membrane-bound cytokine expression and function in engineered T cellsMara C Inniss, Sean G Smith, Dan Jun Li, et al.
Journal of Virology|July 1, 2006
Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile VirusMark Throsby, Cecile Geuijen, Jaap Goudsmit, et al.
Plos Medicine|June 27, 2006
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutantsJan ter Meulen, Edward N van den Brink, Leo L M Poon, et al.
Journal of Virology|January 15, 2005
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirusEdward N van den Brink, Jan Ter Meulen, Freek Cox, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2025
IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15Rachel A Burga, Bulent Arman Aksoy, Zheng Ao, et al.
Cancer Immunology Research|February 20, 2026
Potent cytotoxic tumor-infiltrating lymphocytes can be generated from immune-excluded chondrosarcomas using regulatable membrane-bound IL15Zheng Ao, Rusul Al-Marayaty, Bülent Arman Aksoy, et al.
Oncoimmunology|December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Frontiers in Oncology|June 5, 2026
Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case seriesJessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, et al.
JAMA Oncology|October 12, 2023
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled TrialYongwoo David Seo, Hailing Lu, Graeme Black, et al.
Pageof 6